Yeast Cells as Antioxidant-Producing Probiotics

Sponsor
Benha University (Other)
Overall Status
Completed
CT.gov ID
NCT02814695
Collaborator
Hawaa Fertility Center (Other), Zagazig University (Other)
40
1
4
14.8
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the efficacy of Baker's yeast extractions , probiotic antioxidant, in scavenging the oxidative stress status mediated damage on sperm motility,progressive motility and vitality as well as comparing this potency to that of Vitamin E in infertile men.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Vit E
  • Dietary Supplement: Yeast
  • Dietary Supplement: Vit C 1
  • Dietary Supplement: Vit C 2
  • Dietary Supplement: Vit C 3
Phase 1

Detailed Description

The practical part of the study took place from August 2020 to November 2021. The Study population was made up of infertile males attending Hawaa fertility center, banha city, Qaliubiya, Egypt.

40 study samples were collected from patients who indicated willingness to participate in the study and have had 3 to 7 days of sexual abstinence, using the masturbation method and ejaculated in wide mouthed plastic container as described by World Health Organization (WHO).

Samples were allowed to liquefy for 20 minutes and were examined for volume, viscosity, spermatozoa count by Neubauer haemocytometer , oxidative stress level measurement by Oxisperm, percentage of progressive motility and non-progressive motility and sperm vitality.

The Semen specimens were divided into ten equal fractions. First fraction was control, 0.1ml of liquefied semen mixed with 0.1ml Ham's F10 medium and incubated at 37o C for 30 minutes., 2nd: Vit. E, 3rd (Yeast extraction ( YE).Vitamin C was obtained from (Sigma, Germany), 3rd, 4th, 5th fractions (Vit. C. 1,2,3), 0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (0.02, 0.04, 0.06 mg/ml) Vitamin C respectively and incubated at 37o C for 30 minutes.

After semen specimen treated in all fractions, they were examined and assessed for microscopical changes, total motility, progressive motility, vitality, level of oxidative stress (OS) were detected in all fractions 30 minutes later after addition of the antioxidants.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
control, vit E, vit C, Yeastcontrol, vit E, vit C, Yeast
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Can Yeast Cells Emulate Vitamin E on In-vitro Protection of Human Spermatozoa Against Oxidative Stress?
Actual Study Start Date :
Aug 15, 2020
Actual Primary Completion Date :
Nov 2, 2021
Actual Study Completion Date :
Nov 9, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

First fraction was control, 0.1ml of liquefied semen mixed with 0.1ml Ham's F10 medium and incubated at 37o C for 30 minutes.

Experimental: Vit E supplementation

0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (2 mg/ml) Vitamin E and incubated at 37o C for 30 minutes.

Dietary Supplement: Vit E
0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (2 mg/ml) Vitamin E and incubated at 37o C for 30 minutes.

Experimental: Yeast supplementation

0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (20 mg/ml) Yeast extraction and incubated at 37o C for 30 minutes.

Dietary Supplement: Yeast
0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (20 mg/ml) yeast extraction and incubated at 37o C for 30 minutes.

Experimental: Vit C supplementation

fractions (Vit. C. 1,2,3), 0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (0.02, 0.04, 0.06 mg/ml) Vitamin C respectively and incubated at 37o C for 30 minutes.

Dietary Supplement: Vit C 1
0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (0.02 mg/ml) Vitamin C and incubated at 37o C for 30 minutes.

Dietary Supplement: Vit C 2
0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (0.04 mg/ml) Vitamin C and incubated at 37o C for 30 minutes.

Dietary Supplement: Vit C 3
0.1ml liquefied semen was mixed with 0.1ml Ham's F10 medium supplemented with (0.06 mg/ml) Vitamin C and incubated at 37o C for 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. total motile sperm [30 minutes]

    Number of motile sperms in prepared semen sample per high power field (HPF)

  2. progressive motile sperm [30 minutes]

    Number of progressively-motile sperms in prepared semen sample per HPF

  3. vitality [30 minutes]

    Number of Vital sperms in prepared semen sample per HPF

  4. oxidative stress [30 minutes]

    level of oxidative stress (OS) By Oxisperm Kit

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • must have been married for 1 year before inclusion into the study and were unable to achieve pregnancy

  • must have not received an antibiotic treatment for the last 4 weeks prior to sampling

  • showed oxidative stress- mediated asthenozoospermia in their semen

Exclusion Criteria:
  • Severe male Factor

Contacts and Locations

Locations

Site City State Country Postal Code
1 hawaa Fertility center Banhā Qalyubiya Egypt 13512

Sponsors and Collaborators

  • Benha University
  • Hawaa Fertility Center
  • Zagazig University

Investigators

  • Principal Investigator: Ahmed S Saad, MD, Benha University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Saad, Assistant professor of Ob.&Gyn., Benha University
ClinicalTrials.gov Identifier:
NCT02814695
Other Study ID Numbers:
  • HAWAA-001
First Posted:
Jun 28, 2016
Last Update Posted:
Dec 29, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ahmed Saad, Assistant professor of Ob.&Gyn., Benha University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2021